Zacks Investment Research
01 Apr 2026, 16:41 UTC · 29w ago
Verdict
Headline leans bullish. We score BFLY +1.00.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+1.00strongly bullish
Which stocks this story touches
More positive than 99% of ticker scores this week
The company received FDA clearance for its AI-powered Gestational Age Tool, expanding its addressable market and driving stock gains.
Continue reading
5 related stories
More positive than 99% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
9h ago
+75.7%
Price agrees with the score
$7.10 vs $4.04 close before publication (Mar 31) · not market-adjusted
BFLY chart →
